samedan logo

 
 
spacer
home > ict > winter 2009 > informed integration
PUBLICATIONS
International Clinical Trials

Informed Integration

The biopharmaceutical industry has benefited substantially in recent years from a wide range of eClinical solutions, including electronic data capture (EDC), interactive voice and web response systems (IVRS/IWRS), clinical trial management systems (CTMS), clinical data management systems (CDMS), medical imaging, lab software and electronic patient reported outcomes (ePRO) solutions. While these technologies have significantly improved efficiency and data quality within specific parts of the clinical development process, there remains throughout the industry a critical need to improve the ability to share information and reduce redundant data entry across the clinical enterprise. This lack of data integration and interoperability is preventing biopharmaceutical companies from reaping even greater rewards from their technology systems, such as improved support for ‘go/no-go’ decisions, greater trial productivity and faster product development.

It is apparent that the adoption of eClinical technologies needs to keep pace with the rapid evolution in the global marketplace of biopharmaceutical products. The industry faces an array of challenges, including mounting pressure to improve product development processes, and bring innovative compounds to market more quickly, significantly higher development costs, and growing regulatory demands, especially the need to increase drug safety.

To improve the productivity and efficiency of clinical trials, biopharmaceutical companies must accelerate their implementation of the next generation of eClinical systems and leverage available technologies to better integrate their trial data. While these technology improvements can present their own challenges, the demands of today’s complex healthcare environment make data integration improvements absolutely vital. With greater strategic access to integrated trial information, biopharmaceutical companies will be able to make better development decisions, eliminate inefficient redundancies, reduce trial delays, improve patient safety and speed up time to market.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
David Stein is Perceptive Informatics’ Senior Director of Product Management and plays a pivotal role in managing the company’s products and services, as well as developing new technology solutions to improve the clinical trials process. Prior to joining Perceptive Informatics in 2002, David worked in Strategic Business Development and Marketing at PhaseForward. He also founded, and later sold, an electronic patient reported outcomes company. Earlier in his career, he established and managed the data management department for a mid-sized contract research organisation. David has also served as an independent consultant in the field of pharmaceutical technologies, and has co-developed several custom software packages.

 

spacer
David Stein
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nova Biomedical Launches BioProfile® FLEX2 On-Line Autosampler for Fully Automated Sampling, Analysis, and Feedback Control of up to 10 Bioreactors

Waltham, MA – Nova Biomedical is pleased to announce the launch of the BioProfile FLEX2 On-Line Autosampler (OLS), a modular system that connects as many as 10 bioreactors to one FLEX2 analyzer for up to 3 weeks of walkaway, automated sampling, analysis, and feedback control of key cell culture analytes. The FLEX2 measures up to 16 tests including pH, gases, metabolites, osmolality, cell density, and cell viability.
More info >>

White Papers

Finding the Right End-to-End Safety Solution for Your Needs

Bioclinica

With upcoming changes, including the implementation of the International Conference on Harmonisation (ICH) E2B(R3) Electronic Transmission of Individual Case Safety Report and Identification of Medicinal Products (IDMP) standards, the current state of safety reporting can be confusing. Your existing safety system may not be flexible enough to accommodate these changing regulations, which are still moving targets regarding the details needed for a comprehensive solution with the right level of processes, company-to-company integrations and finalized regional rules.
More info >>

 
Industry Events

SCOPE Summit for Clinical Ops Executives

18-21 February 2020, Hyatt Regency, Orlando, Florida, US

Celebrating its 11th successful year, SCOPE Summit 2020 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 20 different conferences, 3 plenary keynote sessions, the annual Participant Engagement Awards, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement